Cite
MLA Citation
Sahar Khan et al.. “A phase-1 trial of linsitinib (OSI-906) in combination with bortezomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.” Leukemia & lymphoma, vol. 62, no. 7, 2021, pp. 1721–1729. http://access.bl.uk/ark:/81055/vdc_100134871443.0x00002c